---
title: "SAB Biotherapeutics (SABS.US) — Financial Reports"
type: "Symbol"
locale: "en"
url: "https://longbridge.com/en/quote/SABS.US/norm.md"
symbol: "SABS.US"
name: "SAB Biotherapeutics"
parent: "https://longbridge.com/en/quote/SABS.US.md"
datetime: "2026-03-08T06:23:23.559Z"
locales:
  - [en](https://longbridge.com/en/quote/SABS.US/norm.md)
  - [zh-CN](https://longbridge.com/zh-CN/quote/SABS.US/norm.md)
  - [zh-HK](https://longbridge.com/zh-HK/quote/SABS.US/norm.md)
---

> Supported Languages: [简体中文](https://longbridge.com/zh-CN/quote/SABS.US/norm.md) | [繁體中文](https://longbridge.com/zh-HK/quote/SABS.US/norm.md)


# SAB Biotherapeutics (SABS.US) — Financial Reports

## Income Statement (USD)

| Indicator | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 |
| --- | --- | --- | --- | --- | --- |
| EPS | -0.2126 | 0.7491 | -0.5593 | -1.23 | -1.12 |
| ROE | 24.11% | 166.73% | -87.75% | -144.99% | -99.73% |
| Revenue | - | - | - | 114698.00 | - |
| Net income | 5.34M | 6.97M | -5.20M | -11.39M | -10.35M |
| Operating income | -12.68M | -9.73M | -10.77M | -10.01M | -11.31M |
| Gross margin | - | - | - | -6571.14% | - |
| Net margin | - | - | - | -9934.52% | - |
| Profit quality | - | - | - | - | - |

## Balance Sheet (USD)

| Indicator | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 |
| --- | --- | --- | --- | --- | --- |
| A&L | 183.45M | 30.13M | 38.12M | 44.20M | 53.80M |
| Leverage | 1.11 | 2.51 | 1.78 | 1.70 | 1.46 |
| BVPS | 3.48 | 1.29 | 2.30 | 2.80 | 4.00 |
| Turnover | 0.0010 | 0.0025 | 0.0069 | 0.0206 | 0.0368 |
| Cash & STI | 110.88M | 5.71M | 12.85M | 20.76M | 30.40M |
| Inv & Rec | - | - | - | - | - |
| LT assets | 19.44M | 20.40M | 21.37M | 19.92M | 20.75M |
| Net debt | -104.69M | 705092.00 | -6.07M | -16.09M | -25.88M |

## Cash Flow Statement (USD)

| Indicator | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 |
| --- | --- | --- | --- | --- | --- |
| Operating CF | -13.05M | -7.15M | -7.80M | -9.53M | -6.29M |
| Investing CF | -129.87M | 5.20M | 4.67M | 9.33M | -1.15M |
| Financing CF | 168.69M | -173844.00 | -173985.00 | 216961.00 | -674130.00 |
| Free CF | -5.07M | -3.69M | -4.35M | -6.87M | -3.08M |
| OCF coverage | -36270.21% | -4113.77% | -4535.56% | -2893.21% | -839.58% |
| Repaid & issued | - | - | - | 515986.00 | - |
| CapEx | - | - | - | -55377.00 | -100300.00 |